HPV HEAD & NECK FORUM
Sunday, May 30, 2021
Coordinators: E. Rettig (USA), P. Klussmann (Germany)
The EUROGIN HPV and Head & Neck Cancer Forum highlights areas of active investigation in the field of HPV and head and neck cancers. This year's forum will offer an extended review of screening for early cancer detection that will occupy two sessions, molecular characterization and potential biomarkers for prognosis and monitoring of HPV related oropharyngeal cancer patients, new insights on emerging treatment strategies and the role of HPV in benign disease such as recurrent respiratory papillomatosis
A dedicated debate session will focus on the controversies regarding the impact of HPV infection on oro-pharyngeal cancer, including diagnosis, management and decision making.
Overview of Sessions
Subject to change
Epidemiology & Screening
Chair: T. Waterboer (Germany), U. Wieland (Germany)
- HPV vaccination and HPV-OPC prevention • M. Brogli Däppen (Germany)
- Biomarkers for HPV-OPC • E.-S. Prigge (Germany)
- Familial occurence of OPSCC and other HPV-associated cancers • K. Hemminki (Germany)
- Screening for HPV-OPC: Overview of screening concepts • H. Robbins (France)
- Risk-stratified screening of OPSCC - Proof of concept trial • M. Lehtinen (Sweden)
- Cost-effectiveness of OPSCC elimination • S. Vänskä (Sweden)
Management & Surveillance
Chair: P. Bossi (Italy), A. Psyrri (Greece)
- Work up of unknown primary • A. Arora (UK)
- Updates in deintensification • C. J. Busch (Germany)
- Impact of deintensification on HRQOL outcomes • C. Simon (France)
- High-risk & recurrent disease • H. Mehanna (UK)
- Surgical deintensification • T. Jones (UK)
Molecular & Immunologic considerations
Chair: E.-J. Speel (Netherlands), J. Klozar (Czech Republic)
- HPV viral integration • S. Virani (France)
- Molecular modifiers of prognosis in HPV-OPC • L. Licitra (Italy)
- Role of biomarkers in HPV-OPC treatment • N. Wuerdeman (Germany)
- Immune microenvironment in HPV-OPC • T. Dalianis (Sweden)
- HPV-specific T cell response • S. Van der Burg (Netherlands)
Submitted abstracts
Chair: J. P. Klussmann (Germany), H. Mehanna (UK)
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
TRUSTED PARTNER
